TRAFD1
TRAF-type zinc finger domain-containing protein 1
Also known as: FLN29, TRAD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14545
- Gene
- TRAFD1
- Ensembl
- ENSG00000135148
- Chromosome
- 12
- Canonical length
- 582 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The innate immune system confers host defense against viral and microbial infection, and TRAFD1 is a negative feedback regulator that controls excessive immune responses (Sanada et al., 2008 [PubMed 18849341]).[supplied by OMIM, Dec 2009]
Canonical amino-acid sequenceUniProt
582 residues, UniProt reviewed canonical sequence.
>O14545|TRAFD1
1 MAEFLDDQET RLCDNCKKEI PVFNFTIHEI HCQRNIGMCP TCKEPFPKSD METHMAAEHC
61 QVTCKCNKKL EKRLLKKHEE TECPLRLAVC QHCDLELSIL KLKEHEDYCG ARTELCGNCG
121 RNVLVKDLKT HPEVCGREGE EKRNEVAIPP NAYDESWGQD GIWIASQLLR QIEALDPPMR
181 LPRRPLRAFE SDVFHNRTTN QRNITAQVSI QNNLFEEQER QERNRGQQPP KEGGEESANL
241 DFMLALSLQN EGQASSVAEQ DFWRAVCEAD QSHGGPRSLS DIKGAADEIM LPCEFCEELY
301 PEELLIDHQT SCNPSRALPS LNTGSSSPRG VEEPDVIFQN FLQQAASNQL DSLMGLSNSH
361 PVEESIIIPC EFCGVQLEEE VLFHHQDQCD QRPATATNHV TEGIPRLDSQ PQETSPELPR
421 RRVRHQGDLS SGYLDDTKQE TANGPTSCLP PSRPINNMTA TYNQLSRSTS GPRPGCQPSS
481 PCVPKLSNSD SQDIQGRNRD SQNGAIAPGH VSVIRPPQNL YPENIVPSFS PGPSGRYGAS
541 GRSEGGRNSR VTPAAANYRS RTAKAKPSKQ QGAGDAEEEE EELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAFD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- colon: 39 nTPM
- tonsil: 38 nTPM
- lymph node: 35 nTPM
- skin: 35 nTPM
- choroid plexus: 32 nTPM
- esophagus: 31 nTPM
Single-cell type
- early primary spermatocytes: 116 nCPM
- choroid plexus epithelial cells: 62 nCPM
- retinal pigment epithelial cells: 55 nCPM
- urothelial cells: 49 nCPM
- neutrophils: 47 nCPM
- prostatic club cells: 42 nCPM
Immune cell
- basophil: 324 nTPM
- eosinophil: 227 nTPM
- neutrophil: 189 nTPM
- total PBMC: 101 nTPM
- classical monocyte: 96 nTPM
- non-classical monocyte: 94 nTPM
Brain region
- white matter: 46 nTPM
- choroid plexus: 36 nTPM
- medulla oblongata: 32 nTPM
- cerebellum: 29 nTPM
- basal ganglia: 29 nTPM
- pons: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAFD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAFD1 as an antibody target. Whether an autoantibody or antibody against TRAFD1 could matter depends on whether native TRAFD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAFD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAFD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...